David Tapolczay - Apr 22, 2024 Form 4 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)

Role
Chief Executive Officer, Director
Signature
/s/ David Tapolczay
Stock symbol
CDT
Transactions as of
Apr 22, 2024
Transactions value $
$0
Form type
4
Date filed
4/24/2024, 05:00 PM
Previous filing
Dec 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDT Warrant (Right to buy) Award +401K 401K Apr 22, 2024 Common Stock 401K $3.12 Direct F1
transaction CDT Warrant (Right to buy) Sale -200K -50% 200K Apr 22, 2024 Common Stock 200K $3.12 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Warrants issued in exchange for one year lock-up of reporting person's common stock of the company, par value $0.0001 per share, and the payment of $0.125 per warrant.
F2 Warrants sold in exchange for $0.25 per warrant in private transaction.